Novo Nordisk CEO says job cuts affecting 9,000 staff almost complete

COPENHAGEN (Reuters) -Novo Nordisk has notified employees impacted by the drugmaker's job cuts in the vast majority of its locations although the pace varies according to local laws, its CEO Mike Doustdar wrote in a post on LinkedIn on Friday.

Doustdar launched a restructuring drive last month, including 9,000 job cuts globally as Novo faces heated competition in the United States, the world's biggest drug market, against rival Eli Lilly.

(Reporting by Stine Jacobsen, writing by Louise Breusch Rasmussen, editing by)

You May Also Be Interested In

• Blast in Pakistan's Dera Ismail Khan kills 11, injures 30
• White House blocks CNN from Air Force One trip, Washington Post reports
• Swiss National Bank's Schlegel watching hot weather impact on food price inflation